SCHEMBL3143232

SCHEMBL3143232

COC(=O)c1ccc(-c2cccc(NS(C)(=O)=O)c2)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.57
FYN P06241 4/20 0.52
TGFBR1 P36897 1/20 0.52
ACVR1 Q04771 1/20 0.52
KIF11 P52732 1/20 0.50
CHEK1 O14757 2/20 0.49
CLK4 Q9HAZ1 2/20 0.49
AURKA O14965 1/20 0.49
DAPK3 O43293 1/20 0.49
JAK2 O60674 1/20 0.49
ABL1 P00519 1/20 0.49
NTRK1 P04629 1/20 0.49
CSF1R P07333 1/20 0.49
RET P07949 1/20 0.49
IGF1R P08069 1/20 0.49
MET P08581 1/20 0.49
PDGFRB P09619 1/20 0.49
PIM1 P11309 1/20 0.49
FGFR1 P11362 1/20 0.49
PRKACA P17612 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3139471 0.90 FYN (0.52) POLBFYNTGFBR1ACVR1KIF11
SCHEMBL3137569 0.86 FYN (0.52) POLBFYNTGFBR1ACVR1KIF11
SCHEMBL4377535 0.84 FYN (0.47) POLBFYNTGFBR1ACVR1KIF11
SCHEMBL13485182 0.81 POLB (0.71) POLBKIF11BRD4KDM1ASMN1; SMN2
SCHEMBL3138802 0.80 FYN (0.44) POLBFYNTGFBR1ACVR1KIF11
SCHEMBL8200617 0.80 CHEK1 (0.59) POLBCHEK1KDM4EHSD17B10ALDH1A1
SCHEMBL3135122 0.79 CHEK1 (0.60) CHEK1KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL3140624 0.77 CHEK1 (0.52) FYNCHEK1PDGFRBROCK1SMN1; SMN2
SCHEMBL3139186 0.77 CHEK1 (0.52) FYNCHEK1ABL1SMN1; SMN2ALDH1A1
SCHEMBL3133724 0.77 CHEK1 (0.52) POLBCHEK1NTRK1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004221-A1 THIAZEPINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-01-07 US disclosed
EP-2119719-A1 THIAZEPINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004221-A1 THIAZEPINE DERIVATIVE HSD11B1, HSD17B1, HSD3B1 POLB 3795/4885FYN 4502/4885TGFBR1 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.